[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-525915-105":59,"doc-detail-525915-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","safety-and-efficacy-of-ultrafiltration-versus-diuretics-in-patients-with-decompensated-heart-failure-a-systematic-review-and-meta-analysis","Safety and Efficacy of Ultrafiltration Versus Diuretics in Patients With Decompensated Heart Failure - A Systematic Review and Meta-Analysis","","Background: Ultrafiltration (UF) is used for fluid removal in acute decompensated heart failure with reduced ejection fraction (HFrEF) refractory to diuretics, but comparative evidence remains limited. Methods: Trials comparing UF and diuretics were identified from online databases to December 2021; major adverse cardiovascular events (MACE) and components were pooled with a random-effects model. Results: Ten trials (838 patients) showed no significant differences at a median 90-day follow-up for MACE, all-cause mortality, or key utilization and rehospitalization outcomes. Conclusion: UF appears safe but does not clearly reduce mortality or readmission versus diuretics.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/safety-and-efficacy-of-ultrafiltration-versus-diuretics-in-patients-with-decompensated-heart-failure-a-systematic-review-and-meta-analysis/525915/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/safety-and-efficacy-of-ultrafiltration-versus-diuretics-in-patients-with-decompensated-heart-failure-a-systematic-review-and-meta-analysis/525915.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-10-08",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical question does the meta-analysis address?","Question",{"text":112,"@type":113},"It compares the safety and efficacy of ultrafiltration versus diuretics in patients with acute decompensated heart failure with reduced ejection fraction.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were outcomes such as MACE evaluated?",{"text":117,"@type":113},"Online databases were searched for clinical trials, and MACE (and its components) were pooled using a random-effects model to compute unadjusted odds ratios with 95% confidence intervals.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings for mortality and MACE?",{"text":121,"@type":113},"At a median follow-up of 90 days, there was no significant difference in odds of MACE or all-cause mortality between UF and diuretics groups.",{"name":123,"@type":110,"acceptedAnswer":124},"Did ultrafiltration differ from diuretics in safety-related measures?",{"text":125,"@type":113},"No statistically significant differences were found for hypotension risk and post-therapy creatinine rise between UF and diuretics arms.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},525915,1791564966,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":46,"preview_page_count":19,"preview_urls":148},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","European Journal of Internal Medicine 104 (2022) 41–48  \nContents lists available at ScienceDirect  \nEuropean Journal of Internal Medicine  \njournal [homepage:](homepage: www.elsevier.com/locate/ejim)[ www.elsevier.com/locate/ejim](homepage: www.elsevier.com/locate/ejim)  \n| Original article\u003Cbr>Safety and efficacy of ultrafiltration versus diuretics in patients with decompensated heart failure: A systematic review and meta-analysis | |\n| --- | --- |\n| Waqas Ullaha, *, Muhammad Khawar Sana b, Hamza Usman Mustafa a, Harigopal Sandhyavenuc, Alexander Hajduczoka, Tanveer Mird, David L. Fischmana, Mahek Shah a,\u003Cbr>Yevgeniy Brailovskya, Indranee N. Rajapreyara\u003Cbr>a Department of Cardiovascular Medicine, Thomas Jefferson University Hospitals, Philadelphia, PA, USA b John H Stroger Jr. Hospital of Cook County, Chicago, IL, USA\u003Cbr>c Weiss Memorial Hospital, Chicago, IL, USA d Detroit Medical Center, Detroit, MI, USA |  |\n| A B S T R A C T |  |\n| Background: Ultrafiltration (UF) is used for fluid removal patients with acute decompensated heart failure with reduced ejection fraction (HFrEF) refractory to diuretics. However, data on the relative merits of UF and diuretics are limited.\u003Cbr>Methods: Online databases were queried to identify clinical trials on the comparison of UF and diuretics. The major adverse cardiovascular (MACE) and its components (mortality and re-hospitalizations) were compared using the random-effects model to calculate the unadjusted odds ratio (OR) with its 95% confidence interval (CI).\u003Cbr>Results: A total of 10 clinical trials comprising 838 patients (413 UF, 425 diuretics) were included in the analysis. At a median follow-up of 90 days, there was no significant difference in the odds of MACE (OR 0.71, 95% CI 0.47–1.07) and all-cause mortality (OR 1.08, 95% CI 0.77–1.52) between patients undergoing UF compared with those receiving diuretics therapy. The need for emergency department visits (OR 1.05, 95% CI 0.38–2.90), all-cause admissions (OR 0.97, 95% CI 0.72–1.30) and heart failure-related re-hospitalization (OR 0.47, 95% CI 0.21–1.02) was also similar between the two groups. The in-hospital risk for hypotension (OR 0.49, 0.23–1.04) and post-therapy creatinine rise>0.3 mg/dL (OR 1.18, 95% CI 0.74–1.89) was also not significantly different between the UF and diuretics arms. A sensitivity analysis of MACE and mortality did not show any deviation from the pooled outcomes.\u003Cbr>Conclusions: In patients with HFrEF, UF appears to be safe but might not provide significant benefits in terms of reducing the risk of mortality or readmission rates compared with those treated with diuretics. |  |\n\n1. Introduction  \nAcute decompensated heart failure, a constellation of dyspnea, edema, and fatigue due to volume overload, accounts for the high healthcare costs, projected to increase from $21 billion in 2012 to $70 billion in 2030 [1–4]. Therapies such as diuretics and ultrafiltration (UF) have been explored to target volume overload in patients with HF with reduced ejection fraction (HFrEF). Decongestion with diuretics has proven benefits in terms of decreasing symptoms and HF-related hospitalizations [5]. However, continuous or repeated diuretic use has been linked with decremental responses and increased resistance. Studies have also indicated a less prominent decongestive effect of diuretics inpatients with worsening HF, citing the need for higher doses of diuretics to achieve the same effect (right shift dose-response curve). As such, extracorporeal ultrafiltration (UF) has been proposed as an alternative  \ntherapeutic option for decongestion in these patients [6]. UF can potentially provide a greater decline in the mean pulmonary capillary wedge and right atrial pressure, increasing the stroke volume and cardiac output in diuretics-resistant patients with HFrEF [7]. Some small-scale studies suggest that UF in patients with decompensated HF is associated with lesser HF rehospitalization rates in comparison to diuretic groups","cbCaiu4GMIWWuDu8","https://ap.wps.com/l/cbCaiu4GMIWWuDu8","pdf",3636204,"English","# Introduction\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What clinical question does the meta-analysis address?\",\"answer\":\"It compares the safety and efficacy of ultrafiltration versus diuretics in patients with acute decompensated heart failure with reduced ejection fraction.\"},{\"question\":\"How were outcomes such as MACE evaluated?\",\"answer\":\"Online databases were searched for clinical trials, and MACE (and its components) were pooled using a random-effects model to compute unadjusted odds ratios with 95% confidence intervals.\"},{\"question\":\"What were the key findings for mortality and MACE?\",\"answer\":\"At a median follow-up of 90 days, there was no significant difference in odds of MACE or all-cause mortality between UF and diuretics groups.\"},{\"question\":\"Did ultrafiltration differ from diuretics in safety-related measures?\",\"answer\":\"No statistically significant differences were found for hypotension risk and post-therapy creatinine rise between UF and diuretics arms.\"}]","Safety and Efficacy of Ultrafiltration Versus Diuretics in Patients With Decompensated Heart Failure - A Systematic Review and Meta-Analysis | PDF",1791493942,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/157dbe91b380caff2046e51804c95d70.webp",983,1310,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/ffabd01912a964c47ddc47a110093be3.webp",982,1309,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/c12b35633e1990632841dbc464529ddc.webp",981,1308,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/b81307bd5ddab5f0ef496bc647918528.webp",980,1306]